Patients with serum IL-18 levels less than or equal to 45.005 pg/ml may have a higher risk of disease progression, while serum PD-1 levels less than or equal to 21.350 pg/ml indicate a higher risk of pneumothorax and/or chylothorax. Here, IL18 is linked to pneumothorax.